fashion -WSS

fashion

author：fashion 2025-09-28 02:32:45 - browse：475

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： A new crop of companies is reshaping the health data economy

leisure time

entertainment

WSS

STAT Report: Patient voices and perspectives

RaDonda Vaught case: a double standard for nurses, physicians

4th of July breaks record for highest global temperature ever measured

Truvian presents data for its desktop blood

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

STAT Report: Patient voices and perspectives

leisure time

fashion

entertainment

Supreme Court strikes down use of affirmative action

Biden warns of ‘dark winter’ during final presidental debate

What does generative AI mean for health care? We asked experts

Pfizer's Covid pill remains 89% effective in final analysis, company says

Walensky prepares to leave CDC — and Congress — behind

Connecting traumatic brain injury and domestic violence

Virginia high school admissions case could be legal follow

A new study asks: Are we harming blood donors by taking blood?

Medicare proposal to cover medical devices draws a mixed reaction

The battle over 'scope creep' and who gets to be called 'doctor'

knowledge

Former reverend arrested for allegedly killing 8

RaDonda Vaught case: a double standard for nurses, physicians

Dems pitch expanding Medicare power to negotiate drug prices

Grail is spending more than ever lobbying Congress

What to watch for from Zogenix and Amicus clinical trials

Dems pitch expanding Medicare power to negotiate drug prices

hotspot

leisure time

entertainment

hotspot